Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Deloitte
McKinsey
Citi
Daiichi Sankyo

Generated: June 17, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,238,924

« Back to Dashboard

Summary for Patent: 5,238,924
Title: Treatment of renal diseases with ace inhibitors
Abstract:There is disclosed the use of angiotensin converting enzyme (ACE) inhibitors to alter the progression of renal diseases by affecting intraglomerular hemodynamics and proteinuria; i.e., affecting blood pressure within the functioning, filtering tissue of the kidney and the quantity of albumin in the urine.
Inventor(s): Smith; Ronald D. (Worchester, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ) Brigham & Women's Hospital (Boston, MA)
Application Number:07/721,790
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 5,238,924
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,238,924

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Merck
US Department of Justice
Argus Health
Chinese Patent Office
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.